Ticker Scorecard - ENTA Basics Company: Enanta Pharmaceuticals, Inc. IPO Date: March 21, 2013 Sector: Healthcare Industry: Biotech Market Cap: $171.3M Activated in VL: True Average Daily Range Avg Daily Range: $0.94 | 2.19% Avg Daily Range (30 D): $0.23 | 3.93% Avg Daily Range (90 D): $0.25 | 3.20% Institutional Daily Volume Avg Daily Volume: .19M Avg Daily Volume (30 D): .49M Avg Daily Volume (90 D): .37M Trade Size Avg Trade Size (Sh.): 73 Avg Trade Size (Sh.) (30 D): 100 Avg Trade Size (Sh.) (90 D): 96 Institutional Trades Total Inst.Trades: 2,590 Avg Inst. Trade: $1.8M Avg Inst. Trade (30 D): $1.61M Avg Inst. Trade (90 D): $1.97M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.92M Avg Closing Trade (30 D): $1.15M Avg Closing Trade (90 D): $1.15M Avg Closing Volume: 38.35K     News Nov 4, 2024 @ 6:00 PM Urticaria Clinical Trial Pipeline Accelerates: 20+... Source: Delveinsight May 6, 2024 @ 9:10 PM Enanta Pharmaceuticals (ENTA) Reports Q2 Loss, Top... Source: Zacks Equity Research Feb 7, 2024 @ 10:10 PM Enanta Pharmaceuticals (ENTA) Reports Q1 Loss, Lag... Source: Zacks Equity Research Jan 5, 2024 @ 8:09 AM Strength Seen in Enanta Pharmaceuticals (ENTA): Ca... Source: Zacks Equity Research Dec 20, 2023 @ 11:00 AM The Zacks Analyst Blog Highlights Enanta, OneConne... Source: Zacks Equity Research Financials   TTM Q1 2025 Q3 2024 Basic EPS $-1.05 $-1.07 Diluted EPS $-1.05 $-1.07 Revenue $ $ 16.96M $ 17.97M Gross Profit $ $ $ Net Income / Loss $ -104.93M $ -22.29M $ -22.66M Operating Income / Loss $ $ -23.54M $ -24.19M Cost of Revenue $ $ $ Net Cash Flow $ $ 47.12M $ -27.77M PE Ratio